Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 25 kwi 2024 · The life science industry is at the forefront of addressing some of the most pressing challenges of our time, from healthcare to environmental sustainability. It is a rapidly evolving field, with continuous technological advancements, research methodologies, and global regulatory landscapes shaping its future.

  2. Key findings. Life sciences companies are sophisticated business organizations with high levels of scientific knowledge. But many are still striving to ensure that the technology supporting their back office measures up to the same high standards set in their research laboratories.

  3. 26 lip 2024 · Biotech companies strengthen the nation's status as a life sciences leader, whether they're discovering new treatments or harnessing the power of genetics.

  4. 9 sty 2024 · Article. Beyond the pandemic: The next chapter of innovation in vaccines. May 16, 2024 - Decisive action is vital to accelerate vaccine development across the full range of infectious diseases. Five actions show a... McKinsey Direct. Early adoption of generative AI in commercial life sciences. May 6, 2024 -

  5. lifesciencelogic.com › wp-content › uploadsUS LIFE SCIENCES

    1.0 Executive Summary. The life sciences industry comprises companies operating in the research, development and manufacturing of pharmaceuticals, biotechnology-based food and medicines, medical devices, biomedical technologies, nutraceuticals, cosmeceuticals, food processing, and other products that improve the lives of organisms.

  6. 31 maj 2024 · In our 2024 Global Life Sciences Sector Outlook report, we emphasize on these key trends such as increasing pricing pressures, geopolitical environment, changes in US regulations, and the acceleration of Generative AI (GenAI) adoption to expedite drug discovery, cost reduction and revenue uplift.

  7. 6 lis 2023 · Various drivers of life sciences industry expansion appear well entrenched, acting as a stabilizing force in the near term and a catalyst for long-term growth. The number of drug clinical trials in the U.S. has stabilized to more normal levels since a surge in 2021 but remains elevated (Figure 1).

  1. Ludzie szukają również